Synairgen Share Price | |
---|---|
Price | 4.82 |
Bid | 4.82 |
Ask | 5.49 |
Change | -0.675 (-12.28%) |
Volume | 239,822 |
Open | 5.00 |
High | 5.00 |
Low | 4.82 |
Prev. Close | 5.495 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 201.37m |
Market Capitalisation | £9.71m |
Market Size | 30,000 |
52 Week High | 17.50 |
52 Week High Date | 14-Apr-2023 |
52 Week Low | 4.50 |
52 Week Low Date | 06-Mar-2024 |
# Trades | 17 |
---|---|
Vol. Sold | 133,996 |
Sold Value | £6.69k |
Vol. Bought | 105,826 |
Bought Value | £5.54k |
PE Ratio | -0.550228 |
Earnings | -8.76 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
19-Mar-24 | 13:18:36 | 5.27815 | 37,892 | Buy* | 4.82 | 5.49 | 2,000 | O Ordinary |
19-Mar-24 | 12:55:06 | 4.82 | 3,181 | Sell* | 4.82 | 5.49 | 153.32 | A Automatic Execution |
19-Mar-24 | 10:42:13 | 5.20 | 40,000 | Buy* | 4.82 | 5.49 | 2,080 | O Ordinary |
19-Mar-24 | 10:31:58 | 5.20 | 25,000 | Buy* | 4.82 | 5.49 | 1,300 | O Ordinary |
19-Mar-24 | 10:09:52 | 4.82 | 31 | Sell* | 4.82 | 5.49 | 1.49 | A Automatic Execution |
19-Mar-24 | 10:02:05 | 5.20 | 98 | Buy* | 4.82 | 5.49 | 5.10 | O Ordinary |
19-Mar-24 | 10:01:17 | 4.82 | 110 | Sell* | 4.82 | 5.49 | 5.30 | A Automatic Execution |
19-Mar-24 | 09:42:21 | 5.20 | 1,932 | Buy* | 4.82 | 5.49 | 100.46 | O Ordinary |
19-Mar-24 | 09:37:12 | 4.82 | 145 | Sell* | 4.82 | 5.49 | 6.99 | A Automatic Execution |
19-Mar-24 | 09:16:10 | 4.82 | 149 | Sell* | 4.82 | 5.49 | 7.18 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.42 | GBX | 621 | 8,520 |
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.74 | GBX | 7,899 | 8,520 |
12-Aug-21 | 12-Aug-21 | Exercise of Option | John C Ward held the position of Finance Director at the time of this trade.John C Ward | 1.00 | GBX | 489,148 | 734,092 |
12-Aug-21 | 12-Aug-21 | Sell | Phillip David Monk held the position of Chief Scientific Officer at the time of this trade.Phillip David Monk | 140.00 | GBX | 220,878 | 423,934 |
12-Aug-21 | 12-Aug-21 | Exercise of Option | Phillip David Monk held the position of Chief Scientific Officer at the time of this trade.Phillip David Monk | 1.00 | GBX | 400,212 | 423,934 |
Synairgen is a drug discovery and development company founded to combat severe respiratory diseases. Discover SNG001, our breakthrough treatment for COVID-19.